Dieter Hörsch

Sunitinib Malate for the Treatment of Pancreatic Neuroendocrine Tumors

Éric Raymond, Laëtitia Dahan, Jean‐Luc Raoul et al. · New England Journal of Medicine · 2011 · 2.5K citations

Medicine, Oncology, Pharmacology +11

A Muscle-Specific Insulin Receptor Knockout Exhibits Features of the Metabolic Syndrome of NIDDM without Altering Glucose Tolerance

Jens C. Brüning, M.Dodson Michael, Jonathon N. Winnay et al. · Molecular Cell · 1998 · 1.2K citations · Full text

Medicine, Endocrinology, Molecular Genetics +14

Everolimus plus octreotide long-acting repeatable for the treatment of advanced neuroendocrine tumours associated with carcinoid syndrome (RADIANT-2): a randomised, placebo-controlled, phase 3 study

Marianne Pavel, John D. Hainsworth, Éric Baudin et al. · The Lancet · 2011 · 1.1K citations

Medicine, Oncology, Pharmacotherapy +16

The joint IAEA, EANM, and SNMMI practical guidance on peptide receptor radionuclide therapy (PRRNT) in neuroendocrine tumours

John J. Zaknun, Lisa Bodei, Jan Mueller‐Brand et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2013 · 809 citations · Full text

Medicine, Nuclear Medicine, Oncology +17

ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Neoplasms: Peptide Receptor Radionuclide Therapy with Radiolabelled Somatostatin Analogues

Rodney J. Hicks, Dik J. Kwekkeboom, Eric P. Krenning et al. · Neuroendocrinology · 2017 · 331 citations

Medicine, Nuclear Medicine, Oncology +17